The healthcare community is intrigued by retatrutide, a new dual GIP and GLP-1 receptor that’s showing significant results in preliminary trials . This treatment works by mimicking natural hormones to impact appetite and promote feelings of satisfaction , ultimately contributing to substantial body loss . While currently under investigation and … Read More